Category: Hemodynamics


Importance of Right Heart Catheterization

Dr. Susan Joseph, Advanced Heart Failure Specialist from Baylor University Medical Center, discusses perspectives on management of Impella patients in critical care units, particularly the use of invasive hemodynamic monitoring. PA catheters, or right heart catheterization, provide a minute to minute constant source of information about a patient with shock and their filling pressures, pulmonary … Continue reading “Importance of Right Heart Catheterization”

Dr. Bill O’Neill explains the concept of cardioprotection

What is Cardioprotection? Dr. Bill O’Neill of Henry Ford Health System and co-principle investigator of the FDA STEMI-DTU safety and feasibility RCT, discusses the concept of cardioprotection. Cardioprotection is a cellular response to protect the myocardium from suffering irreversible injury.   IMP-449 Subscribe, or join the conversation by following us on Twitter: @ProtectedPCI

Hemodynamic Benefits of Impella RP® Heart Pump for Right Heart Failure

Dr. William O’Neill and Dr. Mark Anderson, co-principle investigators of the RECOVER-RIGHT clinical trial, and Dr. Seth Bilazarian discuss the hemodynamic benefits of using the Impella RP® heart pump for right heart failure. The Impella RP® is the first and only percutaneous heart pump approved by the FDA as safe and effective for acute right … Continue reading “Hemodynamic Benefits of Impella RP® Heart Pump for Right Heart Failure”

The Science of Hemodynamic Support in the Modern Era

Dr. Mark Goodwin of Advocate Health Care presents a scientific presentation covering key factors to determining hemodynamic support, the technical considerations that have seemingly been overlooked over the past decade and the type of care required for low, medium and high risk patients. Tweet this, subscribe or join the conversation by following us on Twitter: @ProtectedPCI NPS-150-16

The Benefit of Impella® Support During Protected PCI for Revascularization

Drs. John Lasala, Bill O’Neill, Jeff Moses, and Bill Lombardi explain the benefit of Impella support during Protected PCI for revascularization.

Impella 2.5 and Impella CP are now approved by the FDA as safe and effective for use during high-risk PCI procedures. Learn more about the data and the clinical guidelines that support the approval. Additionally, learn how to identify patients who can benefit from Protected PCI and revascularization. Tune into this valuable conversation! Chapters include:
  • Maintaining Hemodynamic stability during high-risk PCI
  • Complete Revascularization is the Therapeutic Goal
  • Clinical Outcomes with PCI
Continue readingThe Benefit of Impella® Support During Protected PCI for Revascularization

How to Start Your Own Protected PCI Program

Dr. Perwaiz Meraj of North Shore University Hospital in Long Island shares his Protected PCI program experiences. He also provides tips and insight on how to get Impella® for Protected PCI and other indications widely adopted in your hospital. Tweet this, subscribe or find educational opportunities near you.

The Evolving Landscape of CAD Treatment for Patients with an Indication for Revascularization

More than 15 million Americans suffer from coronary artery disease (CAD), the leading cause of mortality in the United States. According to the online journal Circulation, CAD patients who fail to modify their lifestyle and/or present poor adherence to a medication regimen aimed to control CAD risk factors often place themselves at higher risk for … Continue reading “The Evolving Landscape of CAD Treatment for Patients with an Indication for Revascularization”

Why Complete Revascularization Should be the Standard for Most High-Risk PCI Cases, Dr. Jeffrey Moses

Dr. Jeffrey Moses, Director of Interventional Cardiac Therapeutics at Columbia University Medical Center, NY and Director of Complex Coronary Interventions at St. Francis Hospital, has been a pioneer in developing the techniques and data to optimize complex PCI. At this year’s Hartzler Interventional Cardiology Symposium, Dr. Moses presents a strong case for why complete revascularization … Continue reading “Why Complete Revascularization Should be the Standard for Most High-Risk PCI Cases, Dr. Jeffrey Moses”